← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2002Last known activity
Aug 27, 2019
Timeline
1990s
- Jun 1, 1996
MolMed S.p.A.— Founded
Drugs by trial phase (15 distinct, 20 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colonic Neoplasms
- Colorectal Neoplasms
- Hematologic Neoplasms
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Mesothelioma
- Multiple Myeloma
- Necrosis
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Sarcoma
- Small Cell Lung Carcinoma
- Suicide
Recent trials (33)
- NCT04097301Lead sponsorPhase 1/Phase 2Aug 27, 2019
- NCT03536039CollaboratorPhase 2Jan 27, 2016
- NCT03804866Study directorPhase 2Mar 31, 2013
- NCT03804866Lead sponsorPhase 2Mar 31, 2013
- NCT01358071Lead sponsorPhase 2Jun 1, 2011
- NCT01358071Study directorPhase 2Jun 1, 2011
- NCT01358084Lead sponsorPhase 2Mar 1, 2011
- NCT01358084Study directorPhase 2Mar 1, 2011
- NCT00484341Study directorPhase 2Oct 1, 2010
- NCT00484341Lead sponsorPhase 2Oct 1, 2010
- NCT01098266Lead sponsorPhase 3Mar 1, 2010
- NCT01098266Study directorPhase 3Mar 1, 2010
- NCT00914628Lead sponsorPhase 3Feb 1, 2010
- NCT00994097Study directorPhase 2Jul 1, 2009
- NCT00994097Lead sponsorPhase 2Jul 1, 2009
Details
- Founded
- Milan, IT Jun 1, 1996
- Last known activity
- Aug 27, 2019